Mark Bouzyk

Mark Bouzyk Ph.D. is a founder of AKESOgen and has served as Chief Scientific Officer since the inception of the company.

Dr. Bouzyk was a Director of the Emory Biomarker Service Center (EBSC), Director, Basic Research Shared Core Resources, Emory Winship Cancer Institute, Emory University as well as Director of the Center for Medical Genomics at Emory University, Atlanta. These facilities were developed by Dr. Bouzyk as state of the art laboratory capabilities to enable high throughput genetic, genomic and microarray biomarker studies ranging from DNA, copy number variation, expression, miRNA and methylation profiling all supported by a robust and flexible data management infrastructure in a Clinical Laboratory Improvement Amendments (CLIA) environment. In addition, to help meet the increasing need for translational medicine solutions and by working closely with other laboratories he developed an infrastructure which provides faster, more cost efficient and streamlined genetic tests using rapidly advancing genetic technologies in a clinical environment. Prior to joining Emory Dr. Bouzyk spent approximately 9 years in a global pharmaceutical company, GlaxoSmithKline, where he served as Director of Genetic Laboratory Sciences leading the company’s high throughput genomic efforts in Europe. Dr. Bouzyk’s interests lie in Pharmacogenetics as well as candidate gene and genomic association studies to identify susceptibility genes for both common and rare diseases particularly in the areas of Oncology, Cardiology, Neurological and Psychiatric disorders.

Dr. Bouzyk holds a Ph.D. in Human Molecular Genetics from University of Hertfordshire and a Bachelor of Science with Honors in Biochemistry from University College London.